Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Coluzzi F, Polati E, Freo U, Grilli M. J Pain Res. 2019;12:1521–1528.
On page 1523, Table 1 caption should read from “Key elements from clinical trials on tapentadol PR in the treatment of OA-related pain in the nonsurgical setting” to “Key elements from clinical trials on tapentadol PR in the treatment of low back pain”.
Following a review of our data post-publication, we found the incorrect table caption for Table 1. The correct caption for Table 1 is shown in this corrigendum. This correction has no impact to the findings of the study. The authors apologize for this error.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]